Literature DB >> 9557700

The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells.

Z Nie1, D Bergeron, R A Subbramanian, X J Yao, F Checroune, N Rougeau, E A Cohen.   

Abstract

Several viral determinants were shown to play a role in the ability of human immunodeficiency virus type 1 (HIV-1) to infect nondividing cells. In particular, Vpr and Gag matrix (MA) were recognized to be involved in the nuclear transport of the viral preintegration complex. The goal of the present study was to evaluate the ability of isogenic HIV-1 viruses harboring different vpr and gag genes to infect nondividing cells. Surprisingly, our results reveal that the introduction of mutations in the MA nuclear localization signal marginally affected the ability of proviruses to establish infection in growth-arrested HeLa or MT4 cells. In contrast, we show that in our experimental system, the absence of Vpr expression leads to a reduction in viral infectivity and production which correlates with a decrease in the synthesis and nuclear transport of proviral DNA as determined by PCR analysis. Moreover, our data demonstrate that this reduction of viral replication is also observed with proviruses containing different mutated Vpr alleles. In particular, the Vpr Q65E mutant, which contains a substitution in the second predicted amphipathic alpha-helical structure located in the central region of the protein, is associated with an impairment of the protein nuclear localization and a concomitant reduction of the nuclear transport of proviral DNA. The results of this study provide evidence that a putative amphipathic alpha-helical structure in the central region of Vpr contains a determinant involved in the nuclear translocation of the preintegration complex in nondividing cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557700      PMCID: PMC109640          DOI: 10.1128/JVI.72.5.4104-4115.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

2.  Sensitive reverse transcriptase assay to detect and quantitate human immunodeficiency virus.

Authors:  M H Lee; K Sano; F E Morales; D T Imagawa
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

3.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 4.  Molecular biology of the human immunodeficiency virus accessory proteins.

Authors:  R A Subbramanian; E A Cohen
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

Review 5.  Macrophage-tropic HIV-1 variants: initiators of infection and AIDS pathogenesis?

Authors:  H Schuitemaker
Journal:  J Leukoc Biol       Date:  1994-09       Impact factor: 4.962

6.  Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM).

Authors:  T M Fletcher; B Brichacek; N Sharova; M A Newman; G Stivahtis; P M Sharp; M Emerman; B H Hahn; M Stevenson
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

7.  Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.

Authors:  C A Spina; J C Guatelli; D D Richman
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions.

Authors:  Y L Lu; P Spearman; L Ratner
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.

Authors:  P Di Marzio; S Choe; M Ebright; R Knoblauch; N R Landau
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.

Authors:  M I Bukrinsky; S Haggerty; M P Dempsey; N Sharova; A Adzhubel; L Spitz; P Lewis; D Goldfarb; M Emerman; M Stevenson
Journal:  Nature       Date:  1993-10-14       Impact factor: 69.504

View more
  22 in total

1.  Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.

Authors:  S P Singh; B Tomkowicz; D Lai; M Cartas; S Mahalingam; V S Kalyanaraman; R Murali; A Srinivasan
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Epstein-Barr virus protein kinase BGLF4 targets the nucleus through interaction with nucleoporins.

Authors:  Chou-Wei Chang; Chung-Pei Lee; Yu-Hao Huang; Pei-Wen Yang; Jiin-Tarng Wang; Mei-Ru Chen
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Importin alpha3 interacts with HIV-1 integrase and contributes to HIV-1 nuclear import and replication.

Authors:  Zhujun Ao; Kallesh Danappa Jayappa; Binchen Wang; Yingfeng Zheng; Sam Kung; Eric Rassart; Reinhard Depping; Matthias Kohler; Eric A Cohen; Xiaojian Yao
Journal:  J Virol       Date:  2010-06-16       Impact factor: 5.103

4.  Importin-alpha promotes passage through the nuclear pore complex of human immunodeficiency virus type 1 Vpr.

Authors:  Masakazu Kamata; Yuko Nitahara-Kasahara; Yoichi Miyamoto; Yoshihiro Yoneda; Yoko Aida
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Characterization of a late entry event in the replication cycle of human immunodeficiency virus type 2.

Authors:  D J Griffiths; M Dittmar; P Clapham; E Thomas
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 6.  The functions of the HIV1 protein Vpr and its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase.

Authors:  Laurieann Casey; Xiaoyun Wen; Carlos M C de Noronha
Journal:  Cytokine       Date:  2010-03-27       Impact factor: 3.861

7.  Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr.

Authors:  M P Sherman; C M de Noronha; M I Heusch; S Greene; W C Greene
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Equine infectious anemia virus Gag p9 function in early steps of virus infection and provirus production.

Authors:  Sha Jin; Chaoping Chen; Ronald C Montelaro
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection.

Authors:  M Hrimech; X J Yao; F Bachand; N Rougeau; E A Cohen
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

10.  Assessment of the role of the central DNA flap in human immunodeficiency virus type 1 replication by using a single-cycle replication system.

Authors:  Zhujun Ao; Xiaojian Yao; Eric A Cohen
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.